Google Vaccine

Could Google and Oxford University spell the end for the flu?

GV, formerly “Google Ventures”, has raised £20million for Vaccitech, a company founded by scientists...

Back to News and Events

Could Google and Oxford University spell the end for the flu?

26th January 2018

News : Commercial

GV, formerly “Google Ventures”, has raised £20million for Vaccitech, a company founded by scientists from Oxford University.

Vaccitech is developing the world’s first universal flu vaccine and the money will help to fund a two year clinical trial of the vaccine, involving roughly 2000 participants.  This is the first time that clinical trials of a universal flu vaccine have progressed beyond stage one testing.

Vaccitech will be hoping that positive data at stage two will prompt existing manufacturers, such as GlaxoSmithKline, to partner with the company and take the vaccine on to the final testing stage.

Even at this early stage, the trial demonstrates the scale of the possibilities when the world’s largest companies and its brightest scientists join forces.

Sign up to our eMagazine

@POOLEALCOCK

Issue 4 of Poole Alcock Insight is here! Grab a coffee and enjoy Augusts edition of our free Emagazine. https://t.co/qOHgJ9313q

Posted 18th August 2020

@POOLEALCOCK

Weve had a 5* review from Ian: Kate Heath and team - once again, amazing https://t.co/QNvMmTlgu2

Posted 29th July 2020

call icon_laptop_add icon_purchase_new icon_purchase_standard icon_quill icon_remortgage icon_sale_purchase icon_sale icon_tick search tail-right (1)Created with Sketch. tail_right tick_circle_green tick_circle